MDM2 AMPLIFICATION, P53 MUTATION, AND P53 ACCUMULATION MALIGNANT FIBROUS HISTIOCYTOMA

被引：0
|
作者：
REID, AH
TSAI, MM
VENZON, DJ
WRIGHT, CF
LACK, EE
OLEARY, TJ
机构：
[1] ARMED FORCES INST PATHOL,WASHINGTON,DC 20306
[2] NCI,BETHESDA,MD 20892
[3] GEORGETOWN UNIV,SCH MED,WASHINGTON,DC
来源：
LABORATORY INVESTIGATION | 1995年 / 72卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A11 / A11
页数：1
相关论文
共 50 条
  • [1] MDM2 amplification, P53 mutation, and accumulation of the P53 gene product in malignant fibrous histiocytoma
    Reid, AH
    Tsai, MM
    Venzon, DJ
    Wright, CF
    Lack, EE
    OLeary, TJ
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1996, 5 (01) : 65 - 73
  • [2] MDM2 AMPLIFICATION AND P53 MUTATION IN MALIGNANT FIBROUS HISTIOCYTOMA
    REID, AH
    TSAI, MM
    WRIGHT, CF
    VENZON, DJ
    OLEARY, TJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 202 - 202
  • [3] p53 gene mutation and MDM2 overexpression in a case of primary malignant fibrous histiocytoma of the jejunum
    Jiao, YF
    Nakamura, S
    Sugai, T
    Habano, W
    Uesugi, N
    Oikawa, M
    Sato, T
    APMIS, 2002, 110 (02) : 165 - 171
  • [4] p53 mutation and MDM2 amplification in inflammatory myofibroblastic tumours
    Yamamoto, H
    Oda, Y
    Saito, T
    Sakamoto, A
    Miyajima, K
    Tamiya, S
    Tsuneyoshi, M
    HISTOPATHOLOGY, 2003, 42 (05) : 431 - 439
  • [5] MDM2 and BCL-2: to p53 or not to p53?
    Wang, Eunice S.
    BLOOD, 2023, 141 (11) : 1237 - 1238
  • [6] Immunoreactivity for p53 and mdm2 and the detection of p53 mutations in human malignant mesothelioma
    Segers, K
    Backhovens, H
    Kumar-Singh, S
    DeVoecht, J
    Ramael, M
    Van Broeckhoven, C
    VanMarck, E
    VIRCHOWS ARCHIV, 1995, 427 (04) : 431 - 436
  • [7] Analysis of p53 and mdm2 proteins in malignant fibrous histiocytoma in absence of gene alteration: prognostic significance
    P. Molina
    A. Pellín
    S. Navarro
    J. Boix
    C. Carda
    A. Llombart-Bosch
    Virchows Archiv, 1999, 435 : 596 - 605
  • [8] Analysis of p53 and mdm2 proteins in malignant fibrous histiocytoma in absence of gene alteration:: prognostic significance
    Molina, P
    Pellín, A
    Navarro, S
    Boix, J
    Carda, C
    Llombart-Bosch, A
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1999, 435 (06): : 596 - 605
  • [9] P53 α-helix mimetics antagonize p53/MDM2 interaction and activate p53
    Chen, LH
    Yin, H
    Farooqi, B
    Sebti, S
    Hamilton, AD
    Chen, JD
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (06) : 1019 - 1025
  • [10] ONCOGENE AMPLIFICATION IN UROTHELIAL CANCERS WITH P53 GENE MUTATION OR MDM2 AMPLIFICATION
    HABUCHI, T
    KINOSHITA, H
    YAMADA, H
    KAKEHI, Y
    OGAWA, O
    WU, WJ
    TAKAHASHI, R
    SUGIYAMA, T
    YOSHIDA, O
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (17) : 1331 - 1335
12345